Aktionärsstruktur der AstraZeneca PLC
Portrait der AstraZeneca Aktie
Das Unternehmen AstraZeneca PLC aus Großbritannien ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Biotechnologie & Pharmazeutika, Pharma tätig.
ASTRAZENECA PHARMA INDIA LTD ist ein Tochterunternehmen von AstraZeneca.
Das Unternehmen AstraZeneca PLC ist in mehr als 74 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares STOXX Europe 600 Health Care UCITS ETF (DE) gewichtet AstraZeneca mit 9,81% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle AstraZeneca Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen AstraZeneca PLC am höchsten gewichtet ist Insgesamt in 74 ETFs enthalten
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
718 News & Informationen zur AstraZeneca Aktie
European Union Orders Extra BioNTech-Pfizer Vaccines Amid J&J Suspension
The European Union, grappling with the potential loss of Johnson & Johnson Covid-19 vaccines, will buy an additional 50 million doses from BioNTech and Pfizer for the quarter, and is in talks to purchase up to 1.8 billion more doses over the next two years.
US futures remain steady, hemmed in by US inflation data and vaccine worries
While Wall Street may be emptier this year, it's still important for many companies – or at least some divisions within them – to be close to st…
The Greenback Continues To Trade Heavily
Forex Analysis by Marc Chandler covering: EUR/USD, GBP/USD, USD/JPY, USD/CHF. Read Marc Chandler's latest article on Investing.com
AstraZeneca, mining stocks pull FTSE 100 higher; Tesco caps gains
By Devik Jain
Euro's Resilience And Price Trajectory
Forex Analysis by Naeem Aslam covering: EUR/USD, AstraZeneca PLC ADR. Read Naeem Aslam's latest article on Investing.com
Inflation Fears Shrugged Off
Market Overview Analysis by MarketPulse (Jeffrey Halley) covering: USD/INR, Pfizer Inc, Johnson & Johnson, US Dollar Index Futures. Read MarketPulse (Jeffrey Halley)'s latest article on Investing.com
Vaccine blood-clot side effect puts focus on immune reaction
Rare cases of clotting that have been seen with two Covid-19 vaccines have put the spotlight on an uncommon reaction that occurs when the body unleashes its…
J&J delay slows vaccine rollout across a world needing shots
The drugmaker suspended shots in Europe after U.S. officials paused vaccinations to review the cases of six women who suffered a type of brain blood clot similar to one reported as a rare side effect of the AstraZeneca vaccine.
J&J Covid-19 Vaccine Pause Spotlights Science of Rare Clotting Disorder — 2nd Update
By Daniela Hernandez and Brianna Abbott
Scientists are racing to gain a better understanding of a rare blood-clotting disorder that affected six recipients of Johnson & Johnson's Covid-19… | April 13, 2021
Evening Update: Canada records first case of blood clot linked to AstraZeneca’s COVID-19 vaccine; retail magnate W. Galen Weston dies at age 80
Also in the news today, in the wake of a government relief plan, Air Canada says it has revised its COVID-19 refund policy
Golden Green, Inc. Buys Alerian MLP ETF, InfraCap MLP ETF, Micron Technology Inc, Sells iShares U.S. Preferred Stock, Invesco Preferred ETF, Square Inc
Golden Green, Inc. Buys Alerian MLP ETF, InfraCap MLP ETF, Micron Technology Inc, Sells iShares U.S. Preferred Stock, Invesco Preferred ETF, Square Inc, Stocks: GTHX,TPIC,HPI,HON,NIO,JGH,AMLP,AMZA,MU,AAL,FLR,X,T, release date:Apr 13, 2021
Chart Of The Day: Fundamentals And Technicals Agree, Pfizer Is Heading Higher
Stocks Analysis by Pinchas Cohen/Investing.com covering: Pfizer Inc, Johnson & Johnson, AstraZeneca PLC ADR, Moderna Inc. Read Pinchas Cohen/Investing.com's latest article on Investing.com
Johnson & Johnson Covid-19 Vaccine Updates: Lower Weekly Supply, Blood Clot Investigations
Johnson & Johnson began the rollout of its single-dose Covid-19 vaccine in the United States in early March 2021. Below are some of the recent updates relating to the vaccine. The supply of J&J’s Covid-19 vaccine is expected to decline by about 85% in the U.S. this week, as the company faces some…
AstraZeneca (AZN) Farxiga COVID-19 Study Fails to Meet Goal
AstraZeneca's (AZN) phase III study on Farxiga in hospitalized COVID-19 patients with pre-existing health conditions fails to show statistical significance for the primary endpoint
AstraZeneca/Oxford Calculations (NASDAQ:AZN)
First up is the latest on the possible clotting side effects seen with Oxford/AZN
View: The same flaws that have long plagued entrepreneurs are now jeopardizing world’s battle to end the pandemic
The government seems to expect Indian manufacturers to produce vaccines on spec, jump through various regulatory hoops and then break all their other remunerative contracts in order to give the final product solely to the Indian state — at grossly insufficient prices.
Analyst Downgrades AstraZeneca Stock Due to Vaccine Side Effect Concerns
The odds of experiencing a fatal blood clot following inoculation with AstraZeneca's COVID-19 vaccine are less than one in a million, but that was enough to spook Argus Research.
Australia Expects Big Delays to Covid-19 Vaccine Rollout
Australia expects its Covid-19 vaccination campaign to be delayed by months because of concerns over side effects from the AstraZeneca vaccine and supply-chain issues.
Asian Equities Under Pressure
Stocks Analysis by MarketPulse (Jeffrey Halley) covering: S&P 500, Dow Jones Industrial Average, S&P/ASX 200, Nikkei 225. Read MarketPulse (Jeffrey Halley)'s latest article on Investing.com
Asia Gets Ali Ba-Bashed; Economic Data Expectations
Market Overview Analysis by MarketPulse (Jeffrey Halley) covering: USD/INR, Pfizer Inc, Johnson & Johnson, United States 10-Year. Read MarketPulse (Jeffrey Halley)'s latest article on Investing.com
Weekly Outlook: RBNZ Decision, U.S. CPIs And China GDP
Market Overview Analysis by JFD Team covering: GBP/USD, AUD/USD, NZD/USD, AUD/NZD. Read JFD Team's latest article on Investing.com
Investment Newsletter
Profit From the Pros is a free resource sent by Zacks.com to our subscribers. Sign up today. Tactics that Work in Good Markets and Bad.
Why ASX travel share prices are slipping today
The Qantas and Webjet share prices are down today after a business quarterly predicted full overseas travel won't return until 2024.
AstraZeneca vaccine unmasks EU split between west and desperate east
Most western members of the European Union announced some restrictions of the vaccines use for younger age groups or halted it completely.
Australia Abandons Vaccine Rollout Target Amid Clot Fear Delays
(Bloomberg) — Prime Minister Scott Morrison said he won’t set a new target date for all Australians to receive their first Covid-19 vaccine dose, as health…
Australia Nixes Vaccine Target; U.S. Cases Steady: Virus Update
Bloomberg News
ASX 200 Weekly Wrap: ASX sees 7,000 points once more
Here on our ASX 200 Foolish Weekly Wrap, we look at the things that moved the S&P/ASX 200 Index and the broader share market last week!
Chile defends Sinovac use amid fresh efficacy questions By Reuters
'The right path' – Chile defends Sinovac use amid fresh efficacy questions
Weekly Review and Calendar Ahead By Investing.com
Energy & Precious Metals – Weekly Review and Calendar Ahead
Week Ahead: Fed’s Inflation Calm Is About To Get Tested
Market Overview Analysis by MarketPulse (Ed Moya) covering: USD/JPY, AUD/USD, NZD/USD, XAU/USD. Read MarketPulse (Ed Moya)'s latest article on Investing.com
Oncocyte Presents New Data at 2021 American Association for Cancer Research Annual Meeting Demonstrating Potential for Pan-Cancer Utility of DetermaIO™
Achieved primary endpoint demonstrating significant correlation between DetermaIO and two-year overall survival rate to atezolizumab in metastatic bladder cancer DetermaIO identified… | April 10, 2021
Biden’s orphaned AstraZeneca supply rises to 20 million doses
The US stockpile of the controversial AstraZeneca Plc coronavirus vaccine has grown to more than 20 million doses, according to people familiar with the matter, even as the shot looks increasingly unlikely to factor into President Joe Biden’s domestic vaccination campaign. AstraZeneca has yet to request Food and Drug Administration…
AstraZeneca-Partner Vaccitech beantragt US-Börsengang
Das Biotech-Startup, das hinter dem gemeinsam von AstraZeneca und der Universität Oxford entwickelten Impfstoff gegen COVID-19 steht, hat am Freitag bei den US-Behörden einen Antrag auf einen Börsengang gestellt. 10.04.2021
3 Stocks That Could Suffer if Biden Gives In to This Pressure
Leaders from across the globe and at home want the new president to break from his past.
Could AstraZeneca's Nasal COVID Vaccine Development Zap Altimmune's Prospects?
The short answer: It depends.
Startup behind AstraZeneca Covid-19 vaccine files for U.S. IPO
U.K.-based Vaccitech, spun out of the University of Oxford in 2016, has been aiming for valuation of around $700 million
Biden loads up on extra shots, fueling vaccine gap worldwide
President Joe Biden has ordered almost enough Covid-19 vaccine to fully inoculate every American adult twice, expanding production as he faces both uncertainty about domestic needs and calls from shot-starved allies to share the US supply. Biden announced Wednesday that he’ll double the US order of Johnson & Johnson’s single-dose…
How Africa can save the world from a never-ending pandemic
As the rest of the world prepares for a vaccine-driven return to normal over the next few months, at her community health center in a poor, working class neighborhood of Cape Town, Andrea Mendelsohn is dreading the arrival of April and May—that’s when the weather will get cooler in the…
BioNTech Recruits Rivals to Boost Covid-19 Vaccine Production
By Bojan Pancevski
The maker of the West's first Covid-19 vaccine is building a new manufacturing alliance that could throw Europe and the rest of the world a lifeline amid a painful shortage… | March 13, 2021
BioNTech Recruits Rivals to Boost Covid-19 Vaccine Production
The German company that joined forces with Pfizer to make the West’s first Covid-19 vaccine is now forming an alliance with other firms, some of them Pfizer rivals, in an effort to meet production targets.